compounding pharmacy tirzepatide lawsuit COMPOUNDED LATEST UPDATE! Tirzepatide compounding! Lawsuit!

For reference on how similar GLP-1 medications handle room temperature exposure, see our article on semaglutide storage in the fridge and what happens if semaglutide gets warm

Before making a switch, careful consideration is needed

Add-on to metformin with or without SGLT2 inhibitor SURPASS-3 (NCT03882970) was a 52-week open-label trial that randomized 1444 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin with or without SGLT2 inhibitor to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin degludec 100 units/mL once daily

FDA Drug Approvals (2022) 9